41.35
Schlusskurs vom Vortag:
$42.83
Offen:
$42.27
24-Stunden-Volumen:
1.90M
Relative Volume:
1.11
Marktkapitalisierung:
$5.37B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-507.65M
KGV:
-8.9891
EPS:
-4.6
Netto-Cashflow:
$-616.24M
1W Leistung:
-7.22%
1M Leistung:
-3.07%
6M Leistung:
+16.84%
1J Leistung:
-61.17%
Vaxcyte Inc Stock (PCVX) Company Profile
Firmenname
Vaxcyte Inc
Sektor
Branche
Telefon
650-837-0111
Adresse
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Vergleichen Sie PCVX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
PCVX
Vaxcyte Inc
|
41.35 | 5.56B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-12 | Eingeleitet | Goldman | Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Eingeleitet | Goldman | Buy |
| 2023-12-07 | Eingeleitet | Mizuho | Buy |
| 2023-04-18 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-03 | Bestätigt | Needham | Buy |
| 2022-12-15 | Eingeleitet | Guggenheim | Buy |
| 2022-11-17 | Eingeleitet | BTIG Research | Buy |
| 2021-12-29 | Fortgesetzt | Jefferies | Buy |
| 2021-06-24 | Fortgesetzt | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | BofA Securities | Buy |
| 2020-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-07-07 | Eingeleitet | Needham | Buy |
Alle ansehen
Vaxcyte Inc Aktie (PCVX) Neueste Nachrichten
Vaxcyte (NASDAQ: PCVX) posts $2.7B cash; expands US fill-finish with up to $1B deal - Stock Titan
Has Vaxcyte Inc. found a price floorDividend Hike & Weekly High Return Stock Forecasts - newser.com
How Vaxcyte Inc. stock reacts to Fed rate cutsJuly 2025 Levels & Low Risk Entry Point Guides - newser.com
Will Vaxcyte Inc. stock continue upward momentum2025 Price Action Summary & Step-by-Step Swing Trade Plans - newser.com
What analyst consensus says on Vaxcyte Inc. stock2025 Market Overview & Real-Time Volume Analysis - newser.com
Is Vaxcyte Inc. (5VA) stock a top hedge fund pickQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com
Will Vaxcyte Inc. benefit from macro trendsSell Signal & Precise Swing Trade Entry Alerts - newser.com
When is the best time to exit Vaxcyte Inc.July 2025 Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
What margin trends mean for Vaxcyte Inc. stockWeekly Risk Summary & Daily Technical Forecast Reports - newser.com
Can Vaxcyte Inc. (5VA) stock attract analyst upgradesJuly 2025 Movers & Daily Volume Surge Signals - newser.com
Risk adjusted return profile for Vaxcyte Inc. analyzedJuly 2025 Reactions & Technical Entry and Exit Alerts - newser.com
Should you wait for a breakout in Vaxcyte Inc.Quarterly Investment Review & Weekly Breakout Stock Alerts - newser.com
Will Vaxcyte Inc. stock benefit from commodity prices2025 Trading Volume Trends & Stock Timing and Entry Methods - newser.com
Quantitative breakdown of Vaxcyte Inc. recent move2025 Price Momentum & Breakout Confirmation Alerts - newser.com
Is Vaxcyte Inc 5VA a good long term investmentFlag and Pennant Patterns & Capital Planning and Optimization - earlytimes.in
Vaxcyte, Inc. $PCVX Position Raised by State of New Jersey Common Pension Fund D - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Is Vaxcyte Inc. stock poised for growthEarnings Beat & Community Supported Trade Ideas - newser.com
Identifying reversal signals in Vaxcyte Inc.Earnings Miss & Advanced Swing Trade Entry Alerts - newser.com
Vaxcyte, Inc. $PCVX Shares Purchased by Jennison Associates LLC - MarketBeat
Will Vaxcyte Inc. stock outperform Nasdaq indexJuly 2025 Sentiment & Low Drawdown Momentum Trade Ideas - newser.com
Does Vaxcyte Inc. show high probability of rebound2025 Analyst Calls & Long-Term Safe Investment Plans - newser.com
Using data tools to time your Vaxcyte Inc. exitBond Market & Fast Entry and Exit Trade Plans - newser.com
Is Vaxcyte Inc. (5VA) stock protected from inflationPortfolio Risk Summary & Fast Entry Momentum Alerts - newser.com
Gillette India The best an Investor can getVolume Spike Alerts & Ride the Wave of Market-Beating Growth - earlytimes.in
Is Vaxcyte Inc a good long term investmentPrice Volatility Patterns & Superior Capital Appreciation - earlytimes.in
What moving averages say about Vaxcyte Inc.July 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com
Finanzdaten der Vaxcyte Inc-Aktie (PCVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):